CuralysMD™ is pleased to share that a new narrative review co-authored by Dr. Ratan Chaudhuri was published recently in Biomolecules.

Read the full article in Biomolecules

The article explores an emerging Barrier-First approach to atopic dermatitis, examining how restoring epidermal barrier biology may extend beyond hydration to influence inflammation, itch signaling, microbial balance, and, ultimately, skin resilience.

The review focuses on isosorbide dicaprylate (IDC) and isosorbide di-(linoleate/oleate) (IDL), and the growing mechanistic, translational, and clinical evidence supporting their complementary and synergistic roles in restoring epidermal barrier function and promoting epidermal resilience.

This body of science provides the foundation for CuralysMD™ powered by SMRTActiv™ technology, translating the Barrier-First approach from scientific evidence into practical support for compromised skin.

The future of atopic dermatitis management may not be only about controlling the next flare, but about building more resilient skin.